Skip to Content

Novogene Co Ltd Class A 688315

Morningstar Rating
CNY 13.08 −0.09 (0.68%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

688315 is trading at a 835% premium.
Price
CNY 13.23
Fair Value
CNY 83.28
Uncertainty
Very High
1-Star Price
CNY 51.19
5-Star Price
CNY 17.56
Economic Moat
Fzs
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if 688315 is a good fit for your portfolio.

Trading Information

Previous Close Price
CNY 13.17
Day Range
CNY 13.0613.49
52-Week Range
CNY 12.1732.80
Bid/Ask
CNY 13.08 / CNY 13.10
Market Cap
CNY 5.44 Bil
Volume/Avg
2.4 Mil / 3.0 Mil

Key Statistics

Price/Earnings (Normalized)
41.91
Price/Sales
2.77
Dividend Yield (Trailing)
0.34%
Dividend Yield (Forward)
Total Yield
0.36%

Company Profile

Novogene Co Ltd is engaged in providing multi-level scientific research and technical services and solutions for life science basic research, medical and clinical application research, and independent development and innovation of genetic testing medical equipment.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Mid Core
Total Number of Employees
2,144

Comparables

Valuation

Metric
688315
000710
688253
Price/Earnings (Normalized)
41.9123.53
Price/Book Value
2.361.682.81
Price/Sales
2.772.868.97
Price/Cash Flow
22.4429.9913.59
Price/Earnings
688315
000710
688253

Financial Strength

Metric
688315
000710
688253
Quick Ratio
1.861.6310.60
Current Ratio
2.402.0211.04
Interest Coverage
109.581,693.02
Quick Ratio
688315
000710
688253

Profitability

Metric
688315
000710
688253
Return on Assets (Normalized)
5.06%−13.01%4.47%
Return on Equity (Normalized)
7.69%−18.59%4.81%
Return on Invested Capital (Normalized)
7.55%−15.87%4.51%
Return on Assets
688315
000710
688253
See how this stock stacks up to its competitors with Morningstar Investor

Biotechnology Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
NVO
Novo Nordisk A/S ADRTnkcxjfkJvx$605.7 Bil
VRTX
Vertex Pharmaceuticals IncMgntjndlFqmpn$116.3 Bil
REGN
Regeneron Pharmaceuticals IncHsbwhpksBwtmv$108.0 Bil
MRNA
Moderna IncQqfpdkmkDwk$62.9 Bil
BNTX
BioNTech SE ADRBxrgcffqPvks$23.9 Bil
ARGX
argenx SE ADRWgdlmwlwrJlbny$22.0 Bil
ALNY
Alnylam Pharmaceuticals IncKhrklnwWmdpfz$18.9 Bil
BMRN
Biomarin Pharmaceutical IncFvtthrlcYpgsn$14.5 Bil
INCY
Incyte CorpNmzrznhZfpfk$12.9 Bil
RPRX
Royalty Pharma PLC Class ACcpjlmftrSygrgh$12.3 Bil

Sponsor Center